Altachem Pharma's mission is to become a GLOBAL PHARMACEUTICAL CO. It is a multi-divisional Canadian company with ties overseas.
AAF owns the WOLRD RIGHTS to the HCG MOLECULE (treatment for KAPOSI SARCOMA).
AAF owns the Canadian rights to the ANTICORT (treatment for AIDS/HIV).
It has ties with China through its new PELLET CORE manufacturing facilities and some other joint ventures. AAF has patents for few generic drugs like BUFFERED ASPIRIN, ANTIBIOTICS, AIDS TESTING KITS. The company operates its own GMP approved manufacturing facilities in Alberta for BREATH KITS and other possible products.
More deals are in progress at the moment.
AAF will look for a NASDAQ listing when it is appropriate!
altachempharma.com
cdnx.ca
Original Bullboards:
stockhouse.com
ragingbull.altavista.com |
